The Government of Canada is actively monitoring the novel COVID-19 and its impact on the supply of prescription and over-the-counter drugs, natural health products and medical devices in Canada. We do this through regular contact with:

  • drug, medical device and natural health products manufacturers and importers
  • provincial, territorial and international partners

They are aware that there may be supply disruptions related to COVID-19 and are monitoring the situation closely.

Companies that market prescription drugs for human use in Canada must report anticipated or actual drug shortages on Drug Shortages Canada. We have contacted companies to remind them of this requirement. Industry stakeholder associations have also been asked to notify us of any early signals of shortages related to COVID-19. Drug and medical device shortage signals can also be reported by the provinces and territories, healthcare professionals or the public.

We will continue to use all available tools to help manage critical national shortages when they happen, and work with partners so that Canadians have access to the medications they need. Learn more about drug shortages in Canada.